Research


New Financing Methods in the Biopharma Industry: A Case Study of Royalty Pharma, Inc.

with Sourya V. Naraharisetti, Journal of Investment Management

View abstract

Financial Orphan Therapies Looking For Adoption

with Vikas Sukhatme, Kathy Fang, Vidula Sukhatme, Health Affairs Blog

View abstract

Open-Source Software for “Financing Drug Discovery for Orphan Diseases”

with David E. Fagnan, Austin A. Gromatzky, Jose-Maria Fernandez, Roger M. Stein

View abstract

Unintended Consequences of Expensive Cancer Therapeutics— The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity

with Tito Fojo, Sham Mailankody, JAMA Otolaryngol Head Neck Surg. Published online July 28, 2014. doi:10.1001/jamaoto.2014.1570.

View abstract

The Origin of Risk Aversion

with Ruixun Zhang, Thomas J. Brennan, Proceedings of the National Academy of Sciences 111(2014), 17777–17782.

View abstract

Dynamic Loss Probabilities and Implications for Financial Regulation

with Thomas J. Brennan, Yale Journal on Regulation 31(2014), 667–694.

View abstract

Dealing with Femtorisks in International Relations

with Aaron Benjamin Frank, Margaret Goud Collins, Simon A. Levin, Joshua Ramo, Ulf Dieckmann, Victor Kremenyuk, Arkady Kryazhimskiy, JoAnne Linnerooth-Bayer, Ben Ramalingam, J. Stapleton Roy, Donald G. Saari, Stefan Thurner, Detlof von Winterfeldt, PNAS (2014)

View abstract

Group Selection as Behavioral Adaptation to Systematic Risk

with Ruixun Zhang, Thomas J. Brennan, PLOS One 9 (2014)

View abstract

Parallel Discovery of Alzheimer’s Therapeutics

with Carole Ho, Jayna Cummings, Kenneth S. Kosik, Science Translational Medicine 241(6), 1-8

View abstract

When Do Stop-Loss Rules Stop Losses?

with Kathryn M. Kaminski, Journal of Financial Markets 18 (2014), 234-254.

View abstract

Follow me on © 2017 Andrew W. Lo, MIT Sloan School of Management. All rights reserved.
Design by: Opus Design